Was OZEMPIC the biggest winner at this year's Oscars? Doctor reveals celebs he believes are on weight-loss drugs - as social media reacts to noticeably slimmed-down attendees
Speculation was rife online last night over which celebrities may have taken Ozempic as the Oscars kicked off in Hollywood, California. Dr Gary Motykie has given his take on who may have used the drug. (Source: the Mail online | Health)
Source: the Mail online | Health - March 11, 2024 Category: Consumer Health News Source Type: news
Dr Google will see you now! Women diagnosed with ovarian cancer look up tell-tale symptoms of deadly disease a YEAR before being diagnosed
Women battling the disease looked up symptoms including weight loss , bladder problems and bloating up to 360 days before being referred to a specialist. (Source: the Mail online | Health)
Source: the Mail online | Health - March 11, 2024 Category: Consumer Health News Source Type: news
Semaglutide Curbs MASLD Severity in People Living With HIV Semaglutide Curbs MASLD Severity in People Living With HIV
Semaglutide improved MASLD in this population, and weight loss associated with its use resulted in no significant changes in physical function, according to two presentations at CROI.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 11, 2024 Category: Endocrinology Tags: Gastroenterology Source Type: news
Cannabis may influence bowel motility
Physicians, health care providers, and medical staff caring for patients who use cannabis should be familiar with the effects of the drug on gut motility and thus nuclear medicine imaging, a recent report advises.
“Understanding the effects of cannabis and weight loss drugs on gut motility – that is the movement of food throughout the body – is essential for nuclear medicine providers,” said Rutger Gunther, MD, in a March 5 news release from the Society of Nuclear Medicine and Molecular Imaging.
Gunther, a radiologist at UT Health San Antonio, and colleagues penned an article published in the March issue of the J...
Source: AuntMinnie.com Headlines - March 11, 2024 Category: Radiology Authors: Will Morton Tags: Subspecialties Nuclear Medicine Nuclear Radiology Source Type: news
Experimental Weight-Loss Pill Twice as Effective as Ozempic, Trial Shows
An experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's shares soaring. The drug amycretin caused people to lose 13 percent of…#danish #novonordisk #amycretin #glp1 #novonordiskeurope #ozempic #danieldrucker #newscientist #martinholstlange #cagrisema (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks
The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market. According to a Goldman Sachs analysis, earlier last year, the global industry for anti-obesity medications (AOMs) reached $6 billion on an annualized basis. By 2030, the sector…#goldmansachs #novonordisk #nvo #novonordisks #amycretin #novo #wegovy #amgen #amgn #easily (Source: Reuters: Health)
Source: Reuters: Health - March 10, 2024 Category: Consumer Health News Source Type: news
Revealed: The very unflattering side-effect of Ozempic... and the experts' guide to fixing it
The Ozempic weight-loss drug has helped many reach their target size and shape already, with little sense of privation at all. But there's a problem. With rapid weight loss comes sag, and lots of it. (Source: the Mail online | Health)
Source: the Mail online | Health - March 10, 2024 Category: Consumer Health News Source Type: news
DR ELLIE CANNON: I am losing weight and don't know why - how can I put it back on?
DR ELLIE CANNON: As people age they can suffer weight loss due to a reduction in muscle, and generally older people do have less of an appetite. (Source: the Mail online | Health)
Source: the Mail online | Health - March 10, 2024 Category: Consumer Health News Source Type: news
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock
Eli Lilly and Novo Nordisk have been among the hottest healthcare stocks to own over the past few years. Since 2021, shares of the two companies are up more than 260%, with Eli Lilly now becoming the most valuable publicly traded healthcare company in the world. Eli Lilly's and Novo Nordisk's…#elililly #novonordisk #goldmansachs #vikingtherapeutics #ozempic #davidjagielski #motleyfool #goldmansachsgroup #missedout (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
Eli Lilly's campaign seeks to resolve weight-loss drug misconceptions
Pharmaceutical giant Eli Lilly and Company is trying to clear up misconceptions about obesity care as it increases investment in its highly popular weight-loss drugs. With the latest phase of Lilly's "Get Better" campaign, the company aims to focus the importance of obesity treatment as a disease,…#elilillyandcompany #lilly #elonmusk #fda #bignight #shame #novo #wegovyandozempic #elililly #lillydirect (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are…#fda #novonordisk #wegovy #johnsharretts #marthagulati #ozempic #medicare #tricianeuman #kff #ahip (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
FDA clears Wegovy manufacturer to market weight-loss drug for heart health
The Food and Drug Administration on Friday approved Wegovy manufacturer Novo Nordisk ' s application to add cardiovascular benefits to the weight-loss drug ' s label. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 8, 2024 Category: Consumer Health News Source Type: news
Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients
The popular weight-loss drug Wegovy can now be used to reduce the risk of stroke, heart attacks and other serious heart problems in patients who are overweight or who have obesity (Source: ABC News: Health)
Source: ABC News: Health - March 8, 2024 Category: Consumer Health News Tags: Health Source Type: news
Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.
The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
[time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
FDA approves Wegovy weight-loss shot for heart disease patients - including those who are not obese
The FDA approved the medication for this use in non-diabetic patients who had heart disease today, following clinical trials showing it slashed the risk of the complications by up to 28 percent. (Source: the Mail online | Health)
Source: the Mail online | Health - March 8, 2024 Category: Consumer Health News Source Type: news
